{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:37:41Z","timestamp":1793147861939,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009580","name":"General Hospital of People\u2019s Liberation Army","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ijtb.2020.10.012","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T20:49:54Z","timestamp":1604522994000},"page":"401-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0333-890X","authenticated-orcid":false,"given":"Wenping","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijtb.2020.10.012_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/d41573-020-00151-8","article-title":"Evolution of the COVID-19 vaccine development landscape","volume":"19","author":"Le","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"30","key":"10.1016\/j.ijtb.2020.10.012_bib2","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)","volume":"117","author":"Escobar","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.ijtb.2020.10.012_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","article-title":"BCG-induced trained immunity: can it offer protection against COVID-19?","volume":"20","author":"O'Neill","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.ijtb.2020.10.012_bib4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","article-title":"Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection","volume":"181","author":"Netea","year":"2020","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.ijtb.2020.10.012_bib5","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2020.8189","article-title":"SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults","volume":"323","author":"Hamiel","year":"2020","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.ijtb.2020.10.012_bib6","first-page":"207","article-title":"Stop playing with data: there is no sound evidence that Bacille Calmette-Gu\u00e9rin may avoid SARS-CoV-2 infection (for now)","volume":"91","author":"Ricc\u00f2","year":"2020","journal-title":"Acta Biomed : Atenei Parmensis"},{"key":"10.1016\/j.ijtb.2020.10.012_bib7","article-title":"BCG vaccine-induced protection from COVID-19 infection, wishful thinking or a game changer?","author":"Escobar","year":"2020","journal-title":"medRxiv"},{"issue":"5","key":"10.1016\/j.ijtb.2020.10.012_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.aller.2020.05.002","article-title":"BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?","volume":"48","author":"Sharma","year":"2020","journal-title":"Allergol Immunopathol"},{"issue":"7820","key":"10.1016\/j.ijtb.2020.10.012_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/d41586-020-02334-0","article-title":"How to stop COVID-19 fuelling a resurgence of AIDS, malaria and tuberculosis","volume":"584","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijtb.2020.10.012_bib10","series-title":"UN-OHRLLS, ITU","article-title":"Economic impact of broadband in LDCs, LLDCs and SIDs","year":"2020"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570720302092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570720302092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:59:00Z","timestamp":1758081540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570720302092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0019570720302092"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2020.10.012","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2020.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}